Stick this on the wall and read between the lines, I have used cap to highlight
Results from the clinical trials have underpinned the Board's confidence in the
performance of the Futura syringe and it is now the Group's intention to move
forward to market launch. An INITIAL launch of the Futura Syringe will be
undertaken by the Group's 40 person sales and marketing team commencing early in
2004. The marketing plan for launch of the product will be presented to the
Group's sales team at the Hypoguard National Sales Meeting in mid-December and
will target key medical products distributors with whom the Group has existing
business relationships. INITIAL sales and marketing activities will be focussed
on GENERATING DEMAND for the product and undertaking in-service training and
demonstrations. The product will be marketed in newly designed packaging under
the FuturaSafety Syringe brand. It is anticipated that following receipt of new
packaging materials (which are currently on order and have a lead time of 12
weeks),(WHY SAY THIS) first orders will be fulfilled commencing in the second quarter of 2004.
The Group is also continuing to explore alternative MAJOR distributor
partnership opportunities for the Futura syringe, which would help to ENSURE
MAXIMUM MARKET PENETRATION FOR THE PRODUCT....BINGO, when they announce that one.